Roger Abramino Levy

13PUBLICATIONS
55CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular medicineMedical molecular engineering of nucleic acids and proteinsRheumatology and arthritisClinical chemistry (incl. diagnostics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 05, 2026
Belimumab prevention against organ damage over 8 years and safety up to 13 years: three pooled open-label, long-term extension SLE studies.

|Apr 05, 2025
Disease-Modifying Therapies in Lupus Nephritis: A Narrative Review Evaluating Currently Used Pharmacologic Agents.

Anca D Askanase, Richard Furie, Maria Dall'Era

|Nov 28, 2024
Renal response status to predict long-term renal survival in patients with lupus nephritis: results from the Toronto Lupus Cohort.

Murray Urowitz, Mary E Georgiou, Zahi Touma

|May 22, 2024
Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations.

Anca D Askanase, Richard A Furie, Maria Dall'Era

|Aug 28, 2023
2023 ACR/EULAR antiphospholipid syndrome classification criteria.

Medha Barbhaiya, Stephane Zuily, Ray Naden

|Aug 03, 2023
Lupus spectrum ambiguity has long-term negative implications for patients.

Ian N Bruce, Joy Buie, Lauren Bloch

Pageof 3

Frequent Collaborators

3 joint publications

Guilherme Ribeiro Ramires de Jesús

3 joint publications

Michelle Petri

3 joint publications

Murray Urowitz

3 joint publications

Holly Quasny